Norges Bank
RYTM icon

Norges Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Norges Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.1M Buy
+685,844
New +$62M 0.01% 874
2026
Q1 		– Sell
-66,213
Closed -$7.09M – 1138
2025
Q4 		$7.09M Buy
+66,213
New +$7.02M ﹤0.01% 1341
2025
Q3 		– Sell
-207,389
Closed -$13.1M – 1262
2025
Q2 		$13.1M Sell
207,389
-16,095
-7% -$986K ﹤0.01% 1242
2025
Q1 		$11.8M Buy
223,484
+17,835
+9% +$989K ﹤0.01% 1260
2024
Q4 		$11.5M Buy
205,649
+139,373
+210% +$7.7M ﹤0.01% 1333
2024
Q3 		$3.47M Buy
66,276
+23,038
+53% +$1.1M ﹤0.01% 1585
2024
Q2 		$1.78M Sell
43,238
-7,632
-15% -$305K ﹤0.01% 1739
2024
Q1 		$2.2M Buy
+50,870
New +$2.23M ﹤0.01% 1727
2022
Q1 		– Sell
-51,161
Closed -$511K – 2224
2021
Q4 		$511K Hold
51,161
– – ﹤0.01% 2149
2021
Q3 		$668K Hold
51,161
– – ﹤0.01% 2183
2021
Q2 		$1M Sell
51,161
-13,947
-21% -$290K ﹤0.01% 2117
2021
Q1 		$1.39M Sell
65,108
-94,320
-59% -$2.74M ﹤0.01% 2025
2020
Q4 		$4.74M Hold
159,428
– – ﹤0.01% 1878
2020
Q3 		$3.46M Sell
159,428
-70,767
-31% -$1.62M ﹤0.01% 1915
2020
Q2 		$5.13M Hold
230,195
– – ﹤0.01% 1860
2020
Q1 		$3.5M Hold
230,195
– – ﹤0.01% 1872
2019
Q4 		$5.29M Buy
+230,195
New +$5.11M ﹤0.01% 1906
2018
Q3 		– Sell
-30,000
Closed -$938K – 2157
2018
Q2 		$938K Sell
30,000
-20,000
-40% -$547K ﹤0.01% 2073
2018
Q1 		$995K Hold
50,000
– – ﹤0.01% 2061
2017
Q4 		$1.45M Buy
+50,000
New +$1.32M ﹤0.01% 2015

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank's RYTM Position: Q2 2026 in Review

Norges Bank opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 685,844 shares worth $76.1M. The stake represents 0.01% of the portfolio and ranks #874 among its holdings. This is a return to the name: Norges Bank previously reported a position in RYTM as recently as Q4 2025.

Norges Bank first reported a position in RYTM in Q4 2017 and has held it in 20 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Norges Bank held 685,844 shares of Rhythm Pharmaceuticals worth $76.1M as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Norges Bank position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.01% of Norges Bank's portfolio in Q2 2026, its #874 holding.
  • Norges Bank first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.